Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Hannu Romppanen"'
Autor:
Thor Trovik, Juha Hartikainen, Evald Høj Christiansen, Niels Ramsing Holm, Ole Fröbert, Christian Juhl Terkelsen, Michael Maeng, Lisette Okkels Jensen, Jens Aarøe, Thomas Engstrøm, Indulis Kumsars, Matti Niemelä, Andrejs Erglis, Kari Kervinen, Andis Dombrovskis, Vytautas Abraitis, Aleksandras Kibarskis, Gustavs Latkovskis, Dace Sondore, Inga Narbute, Markku Eskola, Hannu Romppanen, Mika Laine, Mikko Pietila, Pål Gunnes, Lasse Hebsgaard, Fredrik Calais, Jan Ravkilde, Terje K Steigen, Leif Thuesen, Jens F Lassen
Publikováno v:
Open Heart, Vol 7, Iss 1 (2020)
BackgroundIt is still uncertain whether coronary bifurcations with lesions involving a large side branch (SB) should be treated by stenting the main vessel and provisional stenting of the SB (simple) or by routine two-stent techniques (complex). We a
Externí odkaz:
https://doaj.org/article/c5b70c97cf7b4fc3a3f7f3b90b9b201d
Autor:
Hannu Romppanen, Pasi P. Karjalainen, Wail Nammas, Nico H.J. Pijls, Jan Van der Heyden, Bernard De Bruyne, Jacques Lalmand, Juhani Airaksinen, Peter Frambach, Jussi Sia, Pim A.L. Tonino, Carlos Collet, Antonio Serra Peñaranda, Kari Kervinen
Publikováno v:
JACC: Cardiovascular Interventions. 13:1697-1705
Objectives This study sought to compare next-generation cobalt-chromium–based titanium-nitride-oxide (TiNO)–coated stents with a platinum-chromium–based biodegradable polymer everolimus-eluting stent (EES) in patients with acute coronary syndro
Autor:
Niels R Holm, Timo Mäkikallio, M Mitchell Lindsay, Mark S Spence, Andrejs Erglis, Ian B A Menown, Thor Trovik, Thomas Kellerth, Gintaras Kalinauskas, Lone Juul Hune Mogensen, Per H Nielsen, Matti Niemelä, Jens F Lassen, Keith Oldroyd, Geoffrey Berg, Peteris Stradins, Simon J Walsh, Alastair N J Graham, Petter C Endresen, Ole Fröbert, Uday Trivedi, Vesa Anttila, David Hildick-Smith, Leif Thuesen, Evald H Christiansen, Mitchell Lindsay, Markku Eskola, Hannu Romppanen, Tholmas Kellerth, Lisette O Jensen, Rikard B A Linder, Markku Pentikainen, Anders Hervold, Adrian Banning, Azfar Zaman, James Cotton, Erlend Eriksen, Sulev Margus, Lone J H Mogensen, Kari Kervinen, Geoff Berg, Colm G Hanratty, Indulis Kumsars, Terje K Steigen, Alastair NJ Graham, Matthias Corbascio, Olli Kajander, Juha Hartikainen, Ves Anttila
Publikováno v:
Holm, N R, Mäkikallio, T, Lindsay, M M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Kellerth, T, Kalinauskas, G, Mogensen, L J H, Nielsen, P H, Niemelä, M, Lassen, J F, Oldroyd, K, Berg, G, Stradins, P, Walsh, S J, Graham, A N J, Endresen, P C, Fröbert, O, Trivedi, U, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & NOBLE investigators 2020, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis : updated 5-year outcomes from the randomised, non-inferiority NOBLE trial ', Lancet, vol. 395, no. 10219, pp. 191-199 . https://doi.org/10.1016/S0140-6736(19)32972-1
Holm, N R, Mäkikallio, T, Lindsay, M M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Kellerth, T, Kalinauskas, G, Mogensen, L J H, Nielsen, P H, Niemelä, M, Lassen, J F, Oldroyd, K, Berg, G, Stradins, P, Walsh, S J, Graham, A N J, Endresen, P C, Fröbert, O, Trivedi, U, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & NOBLE investigators 2020, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis : updated 5-year outcomes from the randomised, non-inferiority NOBLE trial ', The Lancet, vol. 395, no. 10219, pp. 191-199 . https://doi.org/10.1016/S0140-6736(19)32972-1
Holm, N R, Mäkikallio, T, Lindsay, M M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Kellerth, T, Kalinauskas, G, Mogensen, L J H, Nielsen, P H, Niemelä, M, Lassen, J F, Oldroyd, K, Berg, G, Stradins, P, Walsh, S J, Graham, A N J, Endresen, P C, Fröbert, O, Trivedi, U, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & for the NOBLE study investigators 2020, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis : updated 5-year outcomes from the randomised, non-inferiority NOBLE trial ', The Lancet, vol. 395, no. 10219, pp. 191-199 . https://doi.org/10.1016/S0140-6736(19)32972-1
Holm, N R, Mäkikallio, T, Lindsay, M M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Kellerth, T, Kalinauskas, G, Mogensen, L J H, Nielsen, P H, Niemelä, M, Lassen, J F, Oldroyd, K, Berg, G, Stradins, P, Walsh, S J, Graham, A N J, Endresen, P C, Fröbert, O, Trivedi, U, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & NOBLE investigators 2020, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis : updated 5-year outcomes from the randomised, non-inferiority NOBLE trial ', The Lancet, vol. 395, no. 10219, pp. 191-199 . https://doi.org/10.1016/S0140-6736(19)32972-1
Holm, N R, Mäkikallio, T, Lindsay, M M, Spence, M S, Erglis, A, Menown, I B A, Trovik, T, Kellerth, T, Kalinauskas, G, Mogensen, L J H, Nielsen, P H, Niemelä, M, Lassen, J F, Oldroyd, K, Berg, G, Stradins, P, Walsh, S J, Graham, A N J, Endresen, P C, Fröbert, O, Trivedi, U, Anttila, V, Hildick-Smith, D, Thuesen, L, Christiansen, E H & for the NOBLE study investigators 2020, ' Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis : updated 5-year outcomes from the randomised, non-inferiority NOBLE trial ', The Lancet, vol. 395, no. 10219, pp. 191-199 . https://doi.org/10.1016/S0140-6736(19)32972-1
BACKGROUND: Percutaneous coronary intervention (PCI) is increasingly used in revascularisation of patients with left main coronary artery disease in place of the standard treatment, coronary artery bypass grafting (CABG). The NOBLE trial aimed to eva
Autor:
Pekka Porela, Aija Vatanen, Annika Olli, Mikko Pietilä, Jussi M Kärkkäinen, Anssi Perälä, Miriam Müller, Antti Siljander, Hannu Romppanen, Jaakko Eränen, Jerry Tervo, Mikko Minkkinen, Tuomas T. Rissanen, Eeva Palojoki, Sanna Uskela, Pirjo Mäntylä
Publikováno v:
The Lancet. 394:230-239
Summary Background The optimal technique of percutaneous coronary intervention in patients at high bleeding risk is not known. The hypothesis of the DEBUT trial was that percutaneous coronary intervention with drug-coated balloons is non-inferior to
Autor:
Lisette Okkels Jensen, Dace Sondore, Andis Dombrovskis, Hannu Romppanen, Lasse Hebsgaard, Mika Laine, Niels Ramsing Holm, Matti Niemelä, Juha Hartikainen, Inga Narbute, Aleksandras Kibarskis, Vytautas Abraitis, Jan Ravkilde, Michael Maeng, Jens Flensted Lassen, Markku Eskola, Thor Trovik, Kari Kervinen, Pål Gunnes, Andrejs Erglis, Leif Thuesen, Indulis Kumsars, Fredrik Calais, Gustavs Latkovskis, Evald Høj Christiansen, Mikko Pietilä, Ole Fröbert, Christian Juhl Terkelsen, Thomas Engstrøm, Terje K. Steigen, Jens Aarøe
Publikováno v:
Open Heart
Kumsars, I, Holm, N R, Niemelä, M, Erglis, A, Kervinen, K, Christiansen, E H, Maeng, M, Dombrovskis, A, Abraitis, V, Kibarskis, A, Trovik, T, Latkovskis, G, Sondore, D, Narbute, I, Terkelsen, C J, Eskola, M, Romppanen, H, Laine, M, Jensen, L O, Pietila, M, Gunnes, P, Hebsgaard, L, Frobert, O, Calais, F, Hartikainen, J, Aarøe, J, Ravkilde, J, Engstrøm, T, Steigen, T K, Thuesen, L & Lassen, J F 2020, ' Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch : The Nordic-Baltic Bifurcation Study IV ', Open Heart, vol. 7, no. 1, e000947 . https://doi.org/10.1136/openhrt-2018-000947
Nordic Baltic bifurcation study group 2020, ' Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch : the Nordic-Baltic Bifurcation Study IV ', Open Heart, vol. 7, no. 1, pp. e000947 . https://doi.org/10.1136/openhrt-2018-000947
Kumsars, I, Holm, N R, Niemelä, M, Erglis, A, Kervinen, K, Christiansen, E H, Maeng, M, Dombrovskis, A, Abraitis, V, Kibarskis, A, Trovik, T, Latkovskis, G, Sondore, D, Narbute, I, Terkelsen, C J, Eskola, M, Romppanen, H, Laine, M, Jensen, L O, Pietila, M, Gunnes, P, Hebsgaard, L, Frobert, O, Calais, F, Hartikainen, J, Aarøe, J, Ravkilde, J, Engstrøm, T, Steigen, T K, Thuesen, L, Lassen, J F & Nordic Baltic bifurcation study group 2020, ' Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch : the Nordic-Baltic Bifurcation Study IV ', Open Heart, vol. 7, no. 1, e000947 . https://doi.org/10.1136/openhrt-2018-000947
Open Heart, Vol 7, Iss 1 (2020)
Kumsars, I, Holm, N R, Niemelä, M, Erglis, A, Kervinen, K, Christiansen, E H, Maeng, M, Abraitis, V, Kibarskis, A, Trovik, T, Latkovskis, G, Sondore, D, Narbute, I, Terkelsen, C J, Eskola, M, Romppanen, H, Laine, M, Jensen, L O, Pietila, M, Gunnes, P, Hebsgaard, L, Frobert, O, Calais, F, Hartikainen, J, Aarøe, J, Ravkilde, J, Engstrøm, T, Steigen, T K, Thuesen, L, Lassen, J F & Nordic Baltic bifurcation study group 2020, ' Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch : the Nordic-Baltic Bifurcation Study IV ', Open Heart, vol. 7, no. 1, e000947 . https://doi.org/10.1136/openhrt-2018-000947
Kumsars, I, Holm, N R, Niemelä, M, Erglis, A, Kervinen, K, Christiansen, E H, Maeng, M, Dombrovskis, A, Abraitis, V, Kibarskis, A, Trovik, T, Latkovskis, G, Sondore, D, Narbute, I, Terkelsen, C J, Eskola, M, Romppanen, H, Laine, M, Jensen, L O, Pietila, M, Gunnes, P, Hebsgaard, L, Frobert, O, Calais, F, Hartikainen, J, Aarøe, J, Ravkilde, J, Engstrøm, T, Steigen, T K, Thuesen, L & Lassen, J F 2020, ' Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch : The Nordic-Baltic Bifurcation Study IV ', Open Heart, vol. 7, no. 1, e000947 . https://doi.org/10.1136/openhrt-2018-000947
Nordic Baltic bifurcation study group 2020, ' Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch : the Nordic-Baltic Bifurcation Study IV ', Open Heart, vol. 7, no. 1, pp. e000947 . https://doi.org/10.1136/openhrt-2018-000947
Kumsars, I, Holm, N R, Niemelä, M, Erglis, A, Kervinen, K, Christiansen, E H, Maeng, M, Dombrovskis, A, Abraitis, V, Kibarskis, A, Trovik, T, Latkovskis, G, Sondore, D, Narbute, I, Terkelsen, C J, Eskola, M, Romppanen, H, Laine, M, Jensen, L O, Pietila, M, Gunnes, P, Hebsgaard, L, Frobert, O, Calais, F, Hartikainen, J, Aarøe, J, Ravkilde, J, Engstrøm, T, Steigen, T K, Thuesen, L, Lassen, J F & Nordic Baltic bifurcation study group 2020, ' Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch : the Nordic-Baltic Bifurcation Study IV ', Open Heart, vol. 7, no. 1, e000947 . https://doi.org/10.1136/openhrt-2018-000947
Open Heart, Vol 7, Iss 1 (2020)
Kumsars, I, Holm, N R, Niemelä, M, Erglis, A, Kervinen, K, Christiansen, E H, Maeng, M, Abraitis, V, Kibarskis, A, Trovik, T, Latkovskis, G, Sondore, D, Narbute, I, Terkelsen, C J, Eskola, M, Romppanen, H, Laine, M, Jensen, L O, Pietila, M, Gunnes, P, Hebsgaard, L, Frobert, O, Calais, F, Hartikainen, J, Aarøe, J, Ravkilde, J, Engstrøm, T, Steigen, T K, Thuesen, L, Lassen, J F & Nordic Baltic bifurcation study group 2020, ' Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch : the Nordic-Baltic Bifurcation Study IV ', Open Heart, vol. 7, no. 1, e000947 . https://doi.org/10.1136/openhrt-2018-000947
BackgroundIt is still uncertain whether coronary bifurcations with lesions involving a large side branch (SB) should be treated by stenting the main vessel and provisional stenting of the SB (simple) or by routine two-stent techniques (complex). We a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e62c1c349e7ddb2345c02a24a685ca4
https://trepo.tuni.fi/handle/10024/128174
https://trepo.tuni.fi/handle/10024/128174
Publikováno v:
Scandinavian Cardiovascular Journal. 51(5):248-254
We explored the predictors and outcome of poor, versus good, initial TIMI flow in patients with acute coronary syndrome (ACS).We performed post-hoc analysis of a randomized trial of patients presenting with ACS who received 2 comparative stents. Poor
Autor:
Wail Nammas, Hannu Romppanen, Matti Niemelä, Pasi P. Karjalainen, Jussi Sia, Adam de Belder, Mika Laine
Publikováno v:
European Journal of Internal Medicine. 37:43-48
Background The BASE ACS trial demonstrated an outcome of titanium–nitride–oxide-coated bioactive stents (BAS) that was non-inferior to everolimus-eluting stents (EES) in patients presenting with acute coronary syndrome (ACS). We performed a post
Autor:
Hannu Romppanen, Wail Nammas, Juhani Airaksinen, Tuomas Kiviniemi, Ville Varho, Mikko Pietilä, Pasi P. Karjalainen, Jussi Sia
Publikováno v:
International Journal of Cardiology. 227:194-200
Background/objectives Optical coherence tomography (OCT) is widely used for evaluation of healing response to stent implantation. We sought to test the agreement between the 1-mm and 0.6-mm sampling intervals for assessment of the percentage of uncov
Autor:
Tuija Vasankari, Jarkko Piuhola, Olli-Pekka Piira, Antti Ylitalo, Mikko Savontaus, Fausto Biancari, Juhani Airaksinen, Timo H. Mäkikallio, Viivi Vilkki, Hannu Romppanen, Matti Niemelä, Antti Siljander
Publikováno v:
International Journal of Cardiology. 263:29-31
Background The MANTA system is a novel vascular closure device (VCD) and its safety and efficacy were compared to the ProGlide VCD in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI). Methods This is a retrospective stu
Autor:
Wail Nammas, Juhani Airaksinen, Adam de Belder, Pasi P. Karjalainen, Jussi Sia, Hannu Romppanen
Publikováno v:
Angiology. 68:513-518
The Comparison of Bioactive-Stent to the Everolimus-Eluting Stent in Acute Coronary Syndrome (BASE-ACS) trial demonstrated an outcome of titanium-nitride-oxide-coated bioactive stents (BAS) non-inferior to everolimus-eluting stents (EES) in patients